Head-to-Head

Avalo Therapeutics, Inc. Common Stock vs. Johnson & Johnson

AVTX

Avalo Therapeutics, Inc. Common Stock

$7.45 -39.23%

VS JNJ

Johnson & Johnson

$267.61 +3.81%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AVTXJNJ
Market Cap $657.50 million $621.22 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

AVTXJNJ
Dividend Yield — 2.00%

AVTX and JNJ split the dividend factors evenly.

Risk & Sentiment

AVTXJNJ
Short Interest 4.95% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: AVTX overview, AVTX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.